Superficial femoral artery TASC D Registry: Twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia

Journal of Cardiovascular Surgery

Volumn 54, Issue 4, 2013, Pages 433-439

  Lichtenberg, M ^a   Stahlhoff, W ^a   Boese, D ^a  

^a Arnsberg Clinic   (Germany)

Author keywords

Ischemia; Lower extremity; Stents

Indexed keywords

AGED; AMPUTATION; ARTERY OCCLUSION; CLINICAL ARTICLE; CRITICAL LIMB ISCHEMIA; FEMALE; FOLLOW UP; HUMAN; MALE; NITINOL STENT; OBSERVATIONAL STUDY; RECANALIZATION; REGISTER; RESTENOSIS; REVASCULARIZATION; REVIEW; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY OCCLUSION; TREADMILL EXERCISE; WOUND HEALING;

AGED; ALLOYS; AMPUTATION; ANGIOPLASTY, BALLOON; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FEMORAL ARTERY; GERMANY; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGISTRIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY; WOUND HEALING;

EID: 84884968343     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomized controlled trial. Lancet 2005;366:1925-34. (Pubitemid 41713982)
2. Bardbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: An intention to treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
3. Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R. Endovascular treatment of popliteal artery segments p1 and p2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther 2012;19:450-6.
4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes F et al. Inter Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
6. Krankenberg H, Schluter M, Steinkamp HJ. Nitinolstent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 2007;116:285-92. (Pubitemid 47196564)
7. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery twelve - months results from the RESILIENT randomized trial. Circ Cardovasc Interv 2010;3:267-76.
8. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug eluting and bare nitinol stents for the treatment of atherosclerotic lesions inn the superficial femoral artery: long-term results from the SCIRROCO trial. J Endovascular Ther 2006;13:701-10. (Pubitemid 44907633)
9. Dake MD, Scheinen D, Tepe G, Tessarek G, Fanelli F, Bosiers M et al. Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee: Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study 2011;18:613-23.
10. Bosiers M, Torsello G, Gißler HM, Ruef J, Müller-Hülsbeck S, Jahnke T et al. Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the Durability I Study. J Endovasc Ther 2009;16:261-9.
11. Matsamura J. DURABILITY II full data set at 12 months. ISET 2012.
12. Acin F, de Haro J, Bleda S, Varela C, Esparza L. Primary Nitinol Stenting in the Femoropopliteal Occlusive Disease: A Meta-Analysis of Randomized Controlled Trials. J Endovasc Ther 2012;19:585-95.
13. Lichtenberg M, Hailer B. Call for a revised daily practice TASC guideline. Vasa 2012;6:394-5.
14. Ansel G. One-year interim results: Gore VIBRANT clinical study. LINC 2010.
15. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-9. (Pubitemid 46842791)
16. Bosiers M, Deloose K, Peeters P. Durability 200 study. LINC 2011,
17. Deloose K. 4EVER Study 12 months data: CIRSE 2012.